Radiation dosimetry of [18F](N-methyl)benperidol as determined by whole-body PET imaging of primates
Authors:
- 1 May 1997
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 24 (4) , 311-318
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- In Vivo Kinetics of [18F](N-Methyl)Benperidol: A Novel PET Tracer for Assessment of Dopaminergic D2-Like Receptor BindingJournal of Cerebral Blood Flow & Metabolism, 1997
- Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levelsSynapse, 1993
- Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor bindingInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1992
- Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: specificity analysis and comparison with in vitro bindingJournal of Neuroscience, 1991
- Physical characteristics of the ECAT 953B/31: a new high resolution brain positron tomographIEEE Transactions on Medical Imaging, 1991
- Quantification of the whole-body distribution of PET radiopharmaceuticals, applied to 3-N-([18F]fluoroethyl)spiperoneEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- PET measurement of D2 and S2 receptor binding of 3-N-([2?-18F]fluoroethyl)spiperone in baboon brainEuropean Journal of Nuclear Medicine and Molecular Imaging, 1988
- In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptorsLife Sciences, 1987
- A quantitative model for the in vivo assessment of drug binding sites with positron emission tomographyAnnals of Neurology, 1984
- Correction for Scattered Radiation in a Ring Detector Positron Camera by Integral Transformation of the ProjectionsJournal of Computer Assisted Tomography, 1983